{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:45:20Z","timestamp":1791999920598,"version":"4.4.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Global Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>TB, HIV, and AMR are closely related global health challenges. In the context of limited global health funds and insufficient resources, an integrated tuberculosis, HIV and antimicrobial resistance prevention and control method will play an important role in the optimization of resources and cost-effectiveness.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>This study aims to analyze the degree of policy integration for issues of tuberculosis, HIV and antimicrobial resistance in global health strategies and make recommendations for improving global health governance on related issues.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted a thorough analysis of global health policy documents from January 2015 to February 2024, using both quantitative and qualitative approaches. Our focus was on assessing the integration effectiveness of current global health governance mechanisms in addressing tuberculosis, HIV, and antimicrobial resistance from the global governance view based on the content analysis through word frequency analysis and thematic framework analysis. Besides, we conduct a thematic framework analysis of the action plans and policy recommendations outlined in the most recent reports from UNAIDS, Stop TB, and UNEP on HIV, TB and AMR.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The analysis revealed that most documents address TB, HIV, and AMR in isolation, with limited integration and intersectionality. TB and HIV are more frequently linked, while AMR is less associated with the other two. The proposed action lacks specific provisions for joint implementation or monitoring of the evaluation. Additionally, no documented comprehensive overview includes the overall framework of three health priorities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The study found that the current global health governance mechanism is significantly inadequate in dealing with integration solutions among tuberculosis, HIV and antimicrobial resistance. So we propose establishing integrated governance and coordination mechanisms for the same population at both horizontal and vertical levels, including individual, interpersonal, community, institutional, and societal levels, and developing an integrated policy framework to facilitate better resolution to address the association between TB, HIV infection and antimicrobial resistance in a resource-limited context.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical trial number<\/jats:title>\n            <jats:p>Not applicable.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12992-025-01150-3","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:30:04Z","timestamp":1759174204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of integration in WHO\u2019s tuberculosis, HIV, and antimicrobial resistance policies through the social-ecological lens"],"prefix":"10.1186","volume":"21","author":[{"given":"Jian","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Benn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuduo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongfei","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"1150_CR1","unstructured":"World Health Organization. Antimicrobial resistance [Internet]. Geneva: WHO; 2024. [cited 2024 Feb 20]. Available from:https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance."},{"issue":"10325","key":"1150_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","unstructured":"Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0.","journal-title":"Lancet"},{"key":"1150_CR3","unstructured":"World Bank. Drug-resistant infections: a threat to our economic future [Internet]. Washington, DC: World Bank; 2027 [cited 2024 Feb 20]. Available from: https:\/\/www.worldbank.org\/en\/topic\/health\/publication\/drug-resistant-infections-a-threat-to-our-economic-future"},{"key":"1150_CR4","unstructured":"World Health Organization. HIV\/AIDS [Internet]. Geneva: WHO; 2024. [cited 2024 Feb 20]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids."},{"issue":"1","key":"1150_CR5","doi-asserted-by":"publisher","first-page":"2356623","DOI":"10.1080\/17441692.2024.2356623","volume":"19","author":"R Raad","year":"2024","unstructured":"Raad R, et al. Cycles of antibiotic use and emergent antimicrobial resistance in the South African tuberculosis programme (1950-2021): a scoping review and critical reflections on stewardship. Glob Public Health. 2024;19(1):2356623.","journal-title":"Glob Public Health"},{"key":"1150_CR6","doi-asserted-by":"publisher","unstructured":"Knight GM, McQuaid CF, Dodd PJ, Houben RMGJ. Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling. Lancet Infect Dis. 2019;19(8):903\u201312. https:\/\/doi.org\/10.1016\/S1473-3099(19)30307-X.","DOI":"10.1016\/S1473-3099(19)30307-X"},{"key":"1150_CR7","unstructured":"World Health Organization. HIV and AIDS [Internet]. Geneva: WHO; 2024. [cited 2024 Feb 20]. Available from: https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/hiv-aids."},{"key":"1150_CR8","unstructured":"World Health Organization. Global tuberculosis report 2023. Geneva: World Health Organization. 2023 [cited 2024 Dec 19]. Available from: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2023"},{"key":"1150_CR9","unstructured":"Stop TB Partnership. Global plan to end TB 2023\u20132030 [Internet]. Geneva: Stop TB Partnership; 2024 [cited 2024 Feb 20]. Available from: https:\/\/www.stoptb.org\/global-plan-to-end-tb\/global-plan-to-end-tb-2023-2030."},{"key":"1150_CR10","unstructured":"World Health Organization. Antimicrobial resistance: accelerating national and global responses. Seventy-seventh world health Assembly provisional agenda item 11.8 [Internet]. Geneva: WHO; 2024. [cited 2024 Feb 20]. Available from: https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA77\/A77_5-en.pdf."},{"key":"1150_CR11","unstructured":"United Nations Environment Programme. Strengthening environmental action in the one health response to antimicrobial resistance [Internet]. Nairobi: UNEP; 2024. [cited 2024 Feb 20]. Available from: https:\/\/www.unep.org\/resources\/superbugs\/environmental-action."},{"key":"1150_CR12","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). The path that ends AIDS: UNAIDS global AIDS update 2023 [Internet]. Geneva: UNAIDS; 2023. [cited 2024 Feb 20]. Available from: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2023-unaids-global-aids-update_en.pdf."},{"issue":"4","key":"1150_CR13","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3390\/ijerph17041395","volume":"17","author":"T Jiang","year":"2020","unstructured":"Jiang T, Chen XS. Outcome impacts due to pathogen-specific antimicrobial resistance: a narrative review of published literature. Int J Environ Res Public Health. 2020;17(4):1395.","journal-title":"Int J Environ Res Public Health"},{"key":"1150_CR14","unstructured":"World Health Organization. Turning plans into action for antimicrobial resistance (AMR): Working paper 2.0: implementation and coordination. No. WHO\/WSI\/AMR\/2019.2. Geneva: WHO; 2019."},{"key":"1150_CR15","volume-title":"Global action plan on HIV drug resistance 2017-2021","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Global action plan on HIV drug resistance 2017-2021. Geneva: WHO; 2017."},{"key":"1150_CR16","volume-title":"WHO policy guidance on integrated antimicrobial stewardship activities","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. WHO policy guidance on integrated antimicrobial stewardship activities. Geneva: WHO; 2021."},{"issue":"7","key":"1150_CR17","doi-asserted-by":"publisher","first-page":"e046097","DOI":"10.1136\/bmjopen-2020-046097","volume":"11","author":"RS Mastrangelo","year":"2021","unstructured":"Mastrangelo RS, et al. Consideration of antimicrobial resistance and contextual factors in infectious disease guidelines: a systematic survey. BMJ Open. 2021;11(7):e046097.","journal-title":"BMJ Open"},{"issue":"8","key":"1150_CR18","doi-asserted-by":"publisher","first-page":"e987","DOI":"10.1016\/S2214-109X(20)30309-0","volume":"8","author":"GM Knight","year":"2020","unstructured":"Knight GM, Raviglione MC, White RG. No antimicrobial resistance research agenda without tuberculosis. Lancet Global Health. 2020;8(8):e987\u201388.","journal-title":"Lancet Global Health"},{"issue":"4","key":"1150_CR19","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3390\/microorganisms11041050","volume":"11","author":"TM Coque","year":"2023","unstructured":"Coque TM, et al. Antimicrobial resistance in the global health network: Known unknowns and challenges for efficient responses in the 21st century. Microorganisms. 2023;11(4):1050.","journal-title":"Microorganisms"},{"key":"#cr-split#-1150_CR20.1","unstructured":"World Health Organization. Global strategy and targets for tuberculosis prevention, care and control after 2015 (WHA67.1) [Internet]. Geneva: WHO"},{"key":"#cr-split#-1150_CR20.2","unstructured":"2014. [cited 2025 Aug 27]. Available from: https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA67\/A67_R1-en.pdf"},{"key":"1150_CR21","unstructured":"World Health Organization. Global action plan on antimicrobial resistance [Internet]. Geneva: WHO; 2015. [cited 2025 Aug 27]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241509763."},{"key":"1150_CR22","doi-asserted-by":"crossref","unstructured":"Anku PJ, Amo-Adjei J, Doku D, Kumi-Kyereme A. Challenges of scaling-up of TB-HIV integrated service delivery in Ghana: a qualitative study. PLoS One. 2020;15(7):e0235843. [cited 2025 Aug 27]. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0235843.","DOI":"10.1371\/journal.pone.0235843"},{"key":"1150_CR23","unstructured":"World Health Organization. Tuberculosis & HIV [Internet]. Geneva: WHO; [cited 2025 Aug 27]. Available from: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/treatment\/tuberculosis-hiv"},{"issue":"5","key":"1150_CR24","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2471\/BLT.20.268060","volume":"99","author":"K Viney","year":"2021","unstructured":"Viney K, Chua EJY, Johnson P, et al. Evaluation of the 2016\u20132020 regional tuberculosis response framework, WHO Western Pacific region. Bull World Health Organ. 2021;99(5):330\u201341A. https:\/\/doi.org\/10.2471\/BLT.20.268060.","journal-title":"Bull World Health Organ"},{"key":"1150_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/2049-9957-1-13","volume":"1","author":"GA Ansa","year":"2012","unstructured":"Ansa GA, Walley JD, Siddiqi K, Wei X, Katabira ET, Bwanga F, et al. Assessing the impact of TB\/HIV services integration on TB treatment outcomes and their relevance in TB\/HIV monitoring in Ghana. Infect Dis Poverty. 2012;1:13. https:\/\/doi.org\/10.1186\/2049-9957-1-13.","journal-title":"Infect Dis Poverty"},{"issue":"4","key":"1150_CR26","first-page":"312","volume":"10","author":"D Nansera","year":"2010","unstructured":"Nansera D, Bajunirwe F, Kabakyenga J, Asiimwe PK. Opportunities and barriers for implementation of integrated TB and HIV care in lower level health units: experiences from a rural western Ugandan district. Afr Health Sci. 2010;10(4):312\u201319.","journal-title":"Afr Health Sci"},{"key":"1150_CR27","unstructured":"World Health Organization. Global tuberculosis report 2014 [Internet]. Geneva: WHO; 2014. [cited 2024 Oct 20]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241509763."},{"key":"1150_CR28","unstructured":"United Nations. Press release: high-level meeting on antimicrobial resistance [Internet]. New York: UN; 2016. [cited 2024 Feb 20]. Available from: https:\/\/www.un.org\/pga\/71\/2016\/09\/21\/press-release-hl-meeting-on-antimicrobial-resistance\/."},{"key":"1150_CR29","unstructured":"World Health Organization. Preparation for a high-level meeting of the general Assembly on ending tuberculosis: report by the Director-general. Executive board EB142\/16 [Internet]. Geneva: WHO; 2017. [cited 2024 Feb 20]. Available from:https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/EB142\/B142_16-en.pdf."},{"key":"1150_CR30","unstructured":"World Health Organization. Executive board 144th session: provisional agenda and annotated agenda, reports by the Director-General and regional committees, proposed programme budget 2020-2021, and other documents [Internet]. Geneva: WHO; 2024. [cited 2024 Feb 20]. Available from: https:\/\/apps.who.int\/gb\/e\/e_eb144.html."},{"key":"1150_CR31","unstructured":"United Nations. Multi-stakeholder hearing on antimicrobial resistance [Internet]. New York: UN; [cited 2024 Oct 20]. Available from: https:\/\/www.un.org\/pga\/78\/multi-stakeholder-hearing-on-antimicrobial-resistance\/."},{"key":"1150_CR32","unstructured":"United Nations. Zero draft of the political declaration on antimicrobial resistance [Internet]. New York: UN; 2024 May 20. [cited 2024 Oct 20]. Available from: https:\/\/www.un.org\/pga\/wp-content\/uploads\/sites\/108\/2024\/05\/20240520-AMR-Political-Declaration-Zero-Draft_FINAL.pdf."},{"issue":"4","key":"1150_CR33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1370\/afm.983","volume":"7","author":"JM Valderas","year":"2009","unstructured":"Valderas JM, Starfield B, Sibbald B, et al. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7(4):357\u201363.","journal-title":"Ann Fam Med"},{"issue":"45","key":"1150_CR34","first-page":"6","volume":"10","author":"SM Abate","year":"2020","unstructured":"Abate SM, Checkol Y, Mantedafro B, et al. Prevalence and risk factors of mortality among hospitalized patients with COVID-19: a systematic review and meta-analysis. Bull World Health Organ. 2020;10(45):6.","journal-title":"Bull World Health Organ"},{"key":"1150_CR35","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.2147\/COPD.S175706","volume":"14","author":"FME Franssen","year":"2019","unstructured":"Franssen FME, Alter P, Bar N, et al. Personalized medicine for patients with COPD: where are we? Int J Chron Obstruct Pulmon Dis. 2019;14:1465\u201384.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"21","key":"1150_CR36","doi-asserted-by":"publisher","first-page":"e468","DOI":"10.1161\/CIR.0000000000000456","volume":"134","author":"BS Wiggins","year":"2016","unstructured":"Wiggins BS, Saseen JJ, Page RL, et al. Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American heart association. Circulation. 2016;134(21):e468\u201395.","journal-title":"Circulation"},{"issue":"1","key":"1150_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/14740338.2018.1394455","volume":"17","author":"S Bellosta","year":"2018","unstructured":"Bellosta S, Corsini A. Statin drug interactions and related adverse reactions: an update. Expert Opin Drug Saf. 2018;17(1):25\u201337.","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"1150_CR38","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1513\/pats.201208-063ST","volume":"9","author":"LM Fabbri","year":"2012","unstructured":"Fabbri LM, Boyd C, Boschetto P, et al. How to integrate multiple comorbidities in guideline development: article 10 in integrating and coordinating efforts in COPD guideline development. An Off ATS\/ERS Workshop Report. Proc Am Thorac Soc. 2012;9(5):274\u201381.","journal-title":"An Off ATS\/ERS Workshop Report. Proc Am Thorac Soc"},{"key":"1150_CR39","volume-title":"Multiple chronic conditions-a strategic framework: Optimum health and quality of life for individuals with multiple chronic conditions","author":"US Department of Health and Human Services","year":"2010","unstructured":"US Department of Health and Human Services. Multiple chronic conditions-a strategic framework: optimum health and quality of life for individuals with multiple chronic conditions. Washington, DC: US Department of Health and Human Services; 2010."},{"key":"1150_CR40","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jbi.2014.07.016","volume":"52","author":"ST Liaw","year":"2014","unstructured":"Liaw ST, Taggart J, Yu H, et al. Integrating electronic health record information to support integrated care: practical application of ontologies to improve the accuracy of diabetes disease registers. J Biomed Inf. 2014;52:364\u201372.","journal-title":"J Biomed Inf"},{"issue":"1","key":"1150_CR41","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/cts.12884","volume":"14","author":"KB Johnson","year":"2021","unstructured":"Johnson KB, Wei WQ, Weeraratne D, et al. Precision medicine, AI, and the future of personalized health care. Clin Transl Sci. 2021;14(1):86\u201393.","journal-title":"Clin Transl Sci"},{"key":"1150_CR42","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2147\/COPD.S343108","volume":"2022","author":"A Cravo","year":"2022","unstructured":"Cravo A, Attar D, Freeman D, et al. The importance of self-management in the context of personalized care in COPD. Int J Chron Obstruct Pulmon Dis. 2022;2022:231\u201343.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1150_CR43","doi-asserted-by":"crossref","unstructured":"Tomaschek R, Lampart P, Scheel-Sailer A, et al. Improvement strategies for the challenging collaboration of general practitioners and specialists for patients with complex chronic conditions: a scoping review. Int J Integr Care. 2022;22(3).","DOI":"10.5334\/ijic.5970"},{"key":"1150_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13033-020-00410-6","volume":"14","author":"C Ee","year":"2020","unstructured":"Ee C, Lake J, Firth J, et al. An integrative collaborative care model for people with mental illness and physical comorbidities. Int J Ment Health Syst. 2020;14:1\u201316.","journal-title":"Int J Ment Health Syst"},{"issue":"1","key":"1150_CR45","doi-asserted-by":"publisher","first-page":"e0167887","DOI":"10.1371\/journal.pone.0167887","volume":"12","author":"E Titova","year":"2017","unstructured":"Titova E, Salvesen \u00d8, Bentsen SB, et al. Does an integrated care intervention for COPD patients have long-term effects on quality of life and patient activation? A prospective, open, controlled single-center intervention study. PLoS One. 2017;12(1):e0167887.","journal-title":"PLoS One"},{"issue":"1","key":"1150_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/jcm9010019","volume":"9","author":"M Tew","year":"2019","unstructured":"Tew M, Dowsey MM, Choong A, et al. Co-morbidities and sex differences in long-term quality-of-life outcomes among patients with and without diabetes after total knee replacement: five-year data from registry study. J Clin Med. 2019;9(1):19.","journal-title":"J Clin Med"},{"issue":"702","key":"1150_CR47","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.3399\/bjgp20X713897","volume":"71","author":"M Soley-Bori","year":"2021","unstructured":"Soley-Bori M, Ashworth M, Bisquera A, et al. Impact of multimorbidity on healthcare costs and utilisation: a systematic review of the UK literature. Br J Gen Pract. 2021;71(702):e39\u201346.","journal-title":"Br J Gen Pract"},{"key":"1150_CR48","unstructured":"World Health Organization. Report of regional meeting on strengthening health systems to address co-morbidities in the South-East Asia region. Geneva: WHO; 2015."},{"key":"1150_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-016-3373-6","volume":"16","author":"N Meader","year":"2016","unstructured":"Meader N, King K, Moe-Byrne T, et al. A systematic review on the clustering and co-occurrence of multiple risk behaviours. BMC Public Health. 2016;16:1\u20139.","journal-title":"BMC Public Health"},{"issue":"20_suppl","key":"1150_CR50","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/1403494817743893","volume":"46","author":"B Wold","year":"2018","unstructured":"Wold B, Mittelmark MB. Health-promotion research over three decades: The social-ecological model and challenges in implementation of interventions. Scand J Public Health. 2018;46(20_suppl):20\u201326.","journal-title":"Scand J Public Health"},{"key":"1150_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-13-482","volume":"13","author":"S Baral","year":"2013","unstructured":"Baral S, Logie CH, Grosso A, et al. Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics. BMC Public Health. 2013;13:1\u20138.","journal-title":"BMC Public Health"},{"key":"1150_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40545-021-00309-8","volume":"14","author":"MP Joshi","year":"2021","unstructured":"Joshi MP, et al. Strengthening multisectoral coordination on antimicrobial resistance: a landscape analysis of efforts in 11 countries. J Pharm Policy Pract. 2021;14:1\u201317.","journal-title":"J Pharm Policy Pract"},{"issue":"2","key":"1150_CR53","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/heapol\/czp055","volume":"25","author":"R Atun","year":"2010","unstructured":"Atun R, de Jongh T, Secci F, Ohiri K, Adeyi O. Integration of targeted health interventions into health systems: a conceptual framework for analysis. Health Policy Plan. 2010;25(2):104\u201311. https:\/\/doi.org\/10.1093\/heapol\/czp055.","journal-title":"Health Policy (new Y) PlAn"},{"issue":"24","key":"1150_CR54","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1016\/0277-9536(83)90137-5","volume":"17","author":"A Mills","year":"1983","unstructured":"Mills A. Vertical vs horizontal health programmes in Africa: idealism, pragmatism, resources and efficiency. Soc Sci Med. 1983;17(24):1971\u201381. https:\/\/doi.org\/10.1016\/0277-9536(83)90137-5.","journal-title":"Soc Sci Med"},{"key":"1150_CR55","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1744-8603-4-6","volume":"4","author":"G Ooms","year":"2008","unstructured":"Ooms G, Van Damme W, Baker BK, Zeitz P, Schrecker T. The \u2018diagonal\u2019 approach to global fund financing: a cure for the broader malaise of health systems? Glob Health. 2008;4:6. https:\/\/doi.org\/10.1186\/1744-8603-4-6.","journal-title":"Glob Health"},{"key":"1150_CR56","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/9781118509623.ch23","volume-title":"The handbook of global health policy","author":"J Frenk","year":"2014","unstructured":"Frenk J, G\u00f3mez-Dant\u00e9s O, Knaul FM. The health systems agenda: prospects for the diagonal approach. In: Brown G, Yamey G, Wamala S, editors. The handbook of global health policy. Chichester (UK): Wiley\u2011Blackwell; 2014. p. 425\u201339. https:\/\/doi.org\/10.1002\/9781118509623.ch23."},{"key":"1150_CR57","unstructured":"Clarivate. Cortellis Regulatory Intelligence [Internet]. Philadelphia: Clarivate; 2025. [cited 2025 Jul 20]. Available from: https:\/\/clarivate.com\/life-sciences-healthcare\/lp\/cortellis-regulatory-intelligence\/?utm_source=chatgpt.com."},{"key":"1150_CR58","unstructured":"Stop TB partnership [Internet]. Geneva: Stop TB Partnership; [cited 2024 Feb 20]. Available from: https:\/\/www.stoptb.org\/."},{"key":"1150_CR59","unstructured":"Joint United Nations programme on HIV\/AIDS (UNAIDS) [Internet]. Geneva: UNAIDS; [cited 2024 Feb 20]. Available from: https:\/\/www.unaids.org\/en."},{"key":"1150_CR60","unstructured":"United Nations environment programme (UNEP) [Internet]. Nairobi: UNEP; [cited 2024 Feb 20]. Available from: https:\/\/www.unep.org\/."},{"key":"1150_CR61","unstructured":"Dall C. WHO report shows global tuberculosis cases are rising [Internet]. CIDRAP; 2024. [cited 2025 Aug 27]. Available from: https:\/\/www.cidrap.umn.edu\/tuberculosis\/who-report-shows-global-tuberculosis-cases-are-rising."},{"key":"1150_CR62","unstructured":"KFF. The U.S. Government and global tuberculosis efforts [Internet]. San Francisco: KFF; 2024. [cited 2025 Aug 27]. Available from: https:\/\/www.kff.org\/global-health-policy\/the-u-s-government-and-global-tuberculosis-efforts\/."},{"key":"1150_CR63","unstructured":"World Health Organization. Global tuberculosis report 2019: executive summary [Internet]. Geneva: WHO; 2019. [cited 2025 Aug 27]. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/documents\/tuberculosis\/global-tb-report-2019-executive-summary7248223a-1e25-42a6-ada7-a9503c31bb77.pdf?sfvrsn=84d6195b_1%26download=true."},{"key":"1150_CR64","unstructured":"World Health Organization. WHO advises on the use of multidisease testing devices for TB, HIV and hepatitis [Internet]. Geneva: WHO; 2017. [cited 2025 Aug 27]. Available from: https:\/\/www.who.int\/news\/item\/22-06-2017-who-advises-on-the-use-of-multidisease-testing-devices-for-tb-hiv-and-hepatitis."},{"key":"1150_CR65","unstructured":"Food and Agriculture Organization of the United Nations (FAO). Antimicrobial Resistance Multi-Partner Trust Fund (AMR MPTF) [Internet]. Rome: FAO; [cited 2025 Aug 27]. Available from: https:\/\/www.fao.org\/antimicrobial-resistance\/projects\/ongoing\/project-12\/en\/."},{"key":"1150_CR66","unstructured":"World Health Organization; Food and Agriculture Organization of the United Nations; United Nations Environment Programme. World organisation for animal health. Antimicrobial resistance multi-partner trust fund annual report 2021 [Internet]. Geneva: WHO; 2022 May 31. [cited 2025 Aug 27]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240051362."},{"key":"1150_CR67","unstructured":"Dattani S. Drug-resistant tuberculosis is much more expensive to treat [Internet]. Our world in data. 2024. [cited 2025 Aug 27]. Available from: https:\/\/ourworldindata.org\/data-insights\/drug-resistant-tuberculosis-is-much-more-expensive-to-treat."},{"key":"1150_CR68","unstructured":"Quadripartite Joint Secretariat on Antimicrobial Resistance. Global Programme [Internet]. QJS AMR. [cited 2025 Aug 27]. Available from: https:\/\/www.qjsamr.org\/multi-partner-trust-fund\/programmes\/global-programme."},{"key":"1150_CR69","unstructured":"UNAIDS. Fully funded HIV response [Internet]. Geneva: UNAIDS; [cited 2025 Aug 27]. Available from: https:\/\/open.unaids.org\/result-areas\/fully-funded-sustainable-hiv-response."},{"key":"1150_CR70","unstructured":"The Global Fund to Fight AIDS, Tuberculosis and Malaria. Results Report 2024 [Internet]. Geneva: The Global Fund; 2024. [cited 2025 Aug 27]. Available from: https:\/\/www.theglobalfund.org\/en\/results\/."},{"key":"1150_CR71","unstructured":"Dall C. WHO report shows global tuberculosis cases are rising [internet]. CIDRAP. 2024. . [cited 2025 Aug 27]. Available from: https:\/\/www.cidrap.umn.edu\/tuberculosis\/who-report-shows-global-tuberculosis-cases-are-rising."},{"key":"1150_CR72","unstructured":"World Health Organization. HIV drug resistance [Internet]. Geneva: WHO. [cited 2025 Aug 27]. Available from: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/treatment\/hiv-drug-resistance."},{"key":"1150_CR73","doi-asserted-by":"publisher","unstructured":"Kumar V, Cheng SYC. A comparative literature review of integrated approach in health Care in high and low- middle-income countries. Soc Dev Issues. 2023;46(1). https:\/\/doi.org\/10.3998\/sdi.5294.","DOI":"10.3998\/sdi.5294"},{"key":"1150_CR74","doi-asserted-by":"publisher","unstructured":"Herce ME, Morse J, Luhanga D, Harris J, Smith HJ, Besa S, Samungole G, Kancheya N, Muyoyeta M, Reid SE. Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study. BMC Infect Dis. 2018;18(1). https:\/\/doi.org\/10.1186\/s12879-018-3392-2.","DOI":"10.1186\/s12879-018-3392-2"},{"key":"1150_CR75","doi-asserted-by":"publisher","unstructured":"Naidoo K, Gengiah S, Yende-Zuma N, Padayatchi N, Barker P, Nunn A, Subrayen P, Abdool Karim SS. Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol. Implement Sci. 2017;12(1). https:\/\/doi.org\/10.1186\/s13012-017-0661-1.","DOI":"10.1186\/s13012-017-0661-1"},{"key":"1150_CR76","doi-asserted-by":"publisher","first-page":"145","DOI":"10.12688\/gatesopenres.13330.1","volume":"5","author":"F Kachale","year":"2021","unstructured":"Kachale F, Mahaka I, Mhuriro F, Mugambi M, Murungu J, Ncube B, Ncube G, Ndwiga A, Nyirenda R, Otindo V, Carter A, Dunbar M, Fleischman J, Rodrigues J, Segal K. Integration of HIV and sexual and reproductive health in the era of anti-retroviral-based prevention: findings from assessments in Kenya, Malawi and Zimbabwe. Gates Open Res. 2021;5:145. https:\/\/doi.org\/10.12688\/gatesopenres.13330.1.","journal-title":"Gates Open Res"},{"key":"1150_CR77","doi-asserted-by":"publisher","first-page":"100306","DOI":"10.1016\/j.lansea.2023.100306","volume":"18","author":"B Sihombing","year":"2023","unstructured":"Sihombing B, Bhatia R, Srivastava R, Aditama TY, Laxminarayan R, Rijal S. Response to antimicrobial resistance in South-East Asia Region. Lancet Reg Health Southeast Asia. 2023;18:100306. https:\/\/doi.org\/10.1016\/j.lansea.2023.100306.","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"1150_CR78","doi-asserted-by":"publisher","unstructured":"Kalonji D, Mahomed OH. Health system challenges affecting HIV and tuberculosis integration at primary healthcare clinics in Durban, South Africa. Afr J Prim Health Care Fam Med. 2019;11(1). https:\/\/doi.org\/10.4102\/phcfm.v11i1.1831.","DOI":"10.4102\/phcfm.v11i1.1831"},{"key":"1150_CR79","doi-asserted-by":"publisher","unstructured":"Sinai I, Cleghorn F, Kinkel HF. Improving management of tuberculosis in people living with HIV in South Africa through integration of HIV and tuberculosis services: a proof of concept study. BMC Health Serv Res. 2018;18(1). https:\/\/doi.org\/10.1186\/s12913-018-3524-9.","DOI":"10.1186\/s12913-018-3524-9"},{"key":"1150_CR80","doi-asserted-by":"publisher","first-page":"101298","DOI":"10.1016\/j.eclinm.2022.101298","volume":"44","author":"K Naidoo","year":"2022","unstructured":"Naidoo K, Gengiah S, Yende-Zuma N, Mlobeli R, Ngozo J, Memela N, Padayatchi N, Barker P, Nunn A, Karim SSA. Mortality in HIV and tuberculosis patients following implementation of integrated HIV-TB treatment: results from an open-label cluster-randomized trial. EClinicalMedicine. 2022;44:101298. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101298.","journal-title":"EClinicalMedicine"},{"issue":"3","key":"1150_CR81","doi-asserted-by":"publisher","first-page":"444","DOI":"10.9745\/ghsp-d-21-00157","volume":"9","author":"S Gengiah","year":"2021","unstructured":"Gengiah S, Naidoo K, Mlobeli R, Tshabalala MF, Nunn AJ, Padayatchi N, Yende-Zuma N, Taylor M, Barker PM, Loveday M. A quality improvement intervention to inform scale-up of integrated HIV-TB services: lessons learned from KwaZulu-Natal, South Africa. Glob Health Sci Pract. 2021;9(3):444\u201358. https:\/\/doi.org\/10.9745\/ghsp-d-21-00157.","journal-title":"Glob Health Sci Pract"},{"issue":"2","key":"1150_CR82","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/idr15020017","volume":"15","author":"N Dlatu","year":"2023","unstructured":"Dlatu N, Oladimeji KE, Apalata T. Voices from the patients: a qualitative study of the integration of tuberculosis, human Immunodeficiency virus and primary healthcare services in O.R. Tambo District, Eastern Cape, South Africa. Infect Dis Rep. 2023;15(2):158\u201370. https:\/\/doi.org\/10.3390\/idr15020017.","journal-title":"Infect Dis Rep"},{"issue":"4","key":"1150_CR83","doi-asserted-by":"publisher","first-page":"514","DOI":"10.5588\/ijtld.18.0306","volume":"23","author":"J Musaazi","year":"2019","unstructured":"Musaazi J, Sekaggya-Wiltshire C, Kiragga AN, Kalule I, Reynolds SJ, Manabe YC, Castelnuovo B. Sustained positive impact on tuberculosis treatment outcomes of TB-HIV integrated care in Uganda. Int J Tuberc Lung Dis. 2019;23(4):514\u201321. https:\/\/doi.org\/10.5588\/ijtld.18.0306.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"1150_CR84","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/qai.0000000000001862","volume":"79","author":"SM Burnett","year":"2018","unstructured":"Burnett SM, Zawedde-Muyanja S, Hermans SM, Weaver MR, Colebunders R, Manabe YC. Effect of TB\/HIV integration on TB and HIV indicators in rural Ugandan health facilities. JAIDS J Acquir Immune Defic syndr. 2018;79(5):605\u201311. https:\/\/doi.org\/10.1097\/qai.0000000000001862.","journal-title":"JAIDS J Acquir Immune Defic syndr"},{"key":"1150_CR85","doi-asserted-by":"publisher","unstructured":"Herce ME, Bosomprah S, Masiye F, Mweemba O, Edwards JK, Mandyata C, Siame M, Mwila C, Matenga T, Frimpong C, Mugala A, Mbewe P, Shankalala P, Sichone P, Kasenge B, Chunga L, Adams R, Banda B, Mwamba D, et al. Evaluating a multifaceted implementation strategy and package of evidence-based interventions based on WHO PEN for people living with HIV and cardiometabolic conditions in Lusaka, Zambia: protocol for the TASKPEN hybrid effectiveness-implementation stepped wedge cluster randomized trial. Implement Sci Commun. 2024;5(1). https:\/\/doi.org\/10.1186\/s43058-024-00601-z.","DOI":"10.1186\/s43058-024-00601-z"},{"issue":"7","key":"1150_CR86","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1080\/17476348.2021.1921577","volume":"15","author":"BB Rewari","year":"2021","unstructured":"Rewari BB, Kumar A, Mandal PP, Puri AK. HIV TB coinfection - perspectives from India. Expert Rev Respir Med. 2021;15(7):911\u201330. https:\/\/doi.org\/10.1080\/17476348.2021.1921577.","journal-title":"Expert Rev Respir Med"},{"issue":"3","key":"1150_CR87","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1108\/jica-01-2024-0002","volume":"32","author":"S Rautela","year":"2024","unstructured":"Rautela S, Panackal N, Sharma A. Integrated healthcare system in India: a conceptual framework. J Integr Care. 2024;32(3):285\u2013302. https:\/\/doi.org\/10.1108\/jica-01-2024-0002.","journal-title":"J Integr Care"},{"key":"1150_CR88","doi-asserted-by":"publisher","unstructured":"Kadia BM, Aroke D, Njefi KP, Tochie JN, Tianyi FL, Kadia RS, Dimala CA. Systematic review of therapeutic outcomes of multidrug resistant tuberculosis and their predictors in adults receiving integrated treatment of tuberculosis and human immuno-deficiency virus in low- and middle-income countries: a study protocol. Syst Rev. 2020;9(1). https:\/\/doi.org\/10.1186\/s13643-020-01493-5.","DOI":"10.1186\/s13643-020-01493-5"},{"issue":"1_suppl","key":"1150_CR89","doi-asserted-by":"publisher","first-page":"75S","DOI":"10.1177\/0033354920904084","volume":"135","author":"HD Fukuda","year":"2020","unstructured":"Fukuda HD, Randall LM, Meehan T, Cranston K. Leveraging health department capacities, partnerships, and health insurance for infectious disease response in Massachusetts, 2014-2018. Public Health Rep. 2020;135(1_suppl):75S\u201381S. https:\/\/doi.org\/10.1177\/0033354920904084.","journal-title":"Public Health Rep"},{"key":"1150_CR90","doi-asserted-by":"publisher","first-page":"100427","DOI":"10.1016\/j.jctube.2024.100427","volume":"35","author":"M Takamiya","year":"2024","unstructured":"Takamiya M, Takarinda K, Balachandra S, Musuka G, Radin E, Hakim A, Pearson ML, Choto R, Sandy C, Maphosa T, Rogers JH. Missed opportunities for TB diagnostic testing among people living with HIV in Zimbabwe: cross-sectional analysis of the Zimbabwe population-based HIV impact assessment (ZIMPHIA) survey 2015-16. J Clin Tuberc Other Mycobact Dis. 2024;35:100427. https:\/\/doi.org\/10.1016\/j.jctube.2024.100427.","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"issue":"10","key":"1150_CR91","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.5588\/ijtld.14.0108","volume":"18","author":"R Azadi","year":"2014","unstructured":"Azadi R, Carvalho ACC, Trajman A, et al. Cost-effectiveness of isoniazid preventive therapy in people living with HIV: a systematic review. Int J Tuberc Lung Dis. 2014;18(10):1235\u201341. https:\/\/doi.org\/10.5588\/ijtld.14.0108.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"1150_CR92","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.5588\/ijtld.13.0571","volume":"18","author":"S Gupta","year":"2014","unstructured":"Gupta S, Abimbola T, Date A, Suthar AB, Bennett R, Sangrujee N, et al. Cost-effectiveness of the three I\u2019s for HIV\/TB and ART to prevent TB among people living with HIV. Int J Tuberc Lung Dis. 2014;18(10):1159\u201365. https:\/\/doi.org\/10.5588\/ijtld.13.0571.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"1150_CR93","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S1473-3099(11)70145-1","volume":"11","author":"J Uyei","year":"2011","unstructured":"Uyei J, Coetzee D, Macinko J, Guttmacher S. Integrated delivery of HIV and tuberculosis services in sub-saharan Africa: a systematic review. Lancet Infect Dis. 2011;11(11):855\u201367. https:\/\/doi.org\/10.1016\/S1473-3099(11)70145-1.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"1150_CR94","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1128\/AAC.00825-16","volume":"60","author":"S Karanika","year":"2016","unstructured":"Karanika S, Paudel S, Grigoras C, Kalbasi A, Mylonakis E. Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs. Antimicrob Agents chemother. 2016;60(8):4840\u201352. https:\/\/doi.org\/10.1128\/AAC.00825-16.","journal-title":"Antimicrob Agents chemother"},{"issue":"3","key":"1150_CR95","doi-asserted-by":"publisher","first-page":"dlac064","DOI":"10.1093\/jacamr\/dlac064","volume":"4","author":"BLH Wong","year":"2022","unstructured":"Wong BLH, M\u00e5rtensson G. Economic evaluation of antimicrobial stewardship in primary care: a systematic review and quality assessment. JAC Antimicrob Resist. 2022;4(3):dlac064. https:\/\/doi.org\/10.1093\/jacamr\/dlac064.","journal-title":"JAC Antimicrob Resist"},{"issue":"3","key":"1150_CR96","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2471\/BLT.17.198614","volume":"96","author":"R Hasan","year":"2018","unstructured":"Hasan R, Shakoor S, Hanefeld J, Khan M. Integrating tuberculosis and antimicrobial resistance control programmes. Bull World Health Organ. 2018;96(3):194\u2013200. https:\/\/doi.org\/10.2471\/BLT.17.198614.","journal-title":"Bull World Health Organ"},{"issue":"2","key":"1150_CR97","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/tmi.12029","volume":"18","author":"H Legido-Quigley","year":"2013","unstructured":"Legido-Quigley H, Montgomery CM, Khan P, Atun R, Fakoya A, Getahun H, et al. Integrating tuberculosis and HIV services in low- and middle-income countries: a systematic review. Trop Med Int Health. 2013;18(2):199\u2013211. https:\/\/doi.org\/10.1111\/tmi.12029.","journal-title":"Trop Med Int Health"},{"issue":"1","key":"1150_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/heapol\/czp053","volume":"25","author":"R Atun","year":"2010","unstructured":"Atun R, de Jongh T, Secci FV, Ohiri K, Adeyi O. A systematic review of the evidence on integration of targeted health interventions into health systems. Health Policy Plan. 2010;25(1):1\u201314. https:\/\/doi.org\/10.1093\/heapol\/czp053.","journal-title":"Health Policy (new Y) PlAn"},{"key":"1150_CR99","unstructured":"World Health Organization. Global Tuberculosis Report 2023 [Internet]. Geneva: WHO; 2023. [cited 2024 Feb 21]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241503006."},{"key":"1150_CR100","volume-title":"Implementing antimicrobial drug resistance surveillance and containment for HIV, tuberculosis and malaria: An outline for national programmes. No. WHO\/CDS\/CSR\/RMD\/2003.2","author":"World Health Organization","year":"2004","unstructured":"World Health Organization. Implementing antimicrobial drug resistance surveillance and containment for HIV, tuberculosis and malaria: an outline for national programmes. No. WHO\/CDS\/CSR\/RMD\/2003.2. Geneva: WHO; 2004."},{"issue":"11","key":"1150_CR101","doi-asserted-by":"publisher","first-page":"e002244","DOI":"10.1136\/bmjgh-2019-002244","volume":"5","author":"NIHR Global Health Research Unit on Genomic Surveillance of AMR","year":"2020","unstructured":"NIHR Global Health Research Unit on Genomic Surveillance of AMR. Whole-genome sequencing as part of national and international surveillance programmes for antimicrobial resistance: a roadmap. BMJ Glob Health. 2020;5(11):e002244.","journal-title":"BMJ Glob Health"},{"issue":"12","key":"1150_CR102","doi-asserted-by":"publisher","first-page":"e0002247","DOI":"10.1371\/journal.pgph.0002247","volume":"3","author":"M Brunetti","year":"2023","unstructured":"Brunetti M, et al. Application of diagnostic network optimization in Kenya and Nepal to design integrated, sustainable and efficient bacteriology and antimicrobial resistance surveillance networks. PLoS Glob Public Health. 2023;3(12):e0002247.","journal-title":"PLoS Glob Public Health"},{"key":"1150_CR103","unstructured":"Top MM. The South African antimicrobial resistance strategy framework. AMR Control. 2015;54."},{"issue":"6","key":"1150_CR104","first-page":"528","volume":"11","author":"B Godman","year":"2021","unstructured":"Godman B, et al. Strategies to improve antimicrobial utilization with a special focus on developing countries. Life (Basel). 2021;11(6):528.","journal-title":"Life (Basel)"},{"key":"1150_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-020-00822-6","volume":"9","author":"CM Morel","year":"2020","unstructured":"Morel CM, et al. A one health framework to estimate the cost of antimicrobial resistance. Antimicrob Resist Infect Control. 2020;9:1\u201314.","journal-title":"Antimicrob Resist Infect Control"}],"container-title":["Globalization and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12992-025-01150-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12992-025-01150-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12992-025-01150-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:30:15Z","timestamp":1759174215000},"score":1,"resource":{"primary":{"URL":"https:\/\/globalizationandhealth.biomedcentral.com\/articles\/10.1186\/s12992-025-01150-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1150"],"URL":"https:\/\/doi.org\/10.1186\/s12992-025-01150-3","relation":{},"ISSN":["1744-8603"],"issn-type":[{"value":"1744-8603","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have reviewed and approved the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"53"}}